Aims: This study evaluated the antibiotic-induced changes in microbial ecology, intestinal dysbiosis and low-grade inflammation; and the combined effect of four different Lactobacillus species on recovery of microbiota composition and improvement of gut barrier function in mice. Methods and Results: Administration of the antibiotic ampicillin for 2 weeks decreased microbial community diversity, induced caecum tumefaction and increased gut permeability in mice. Application of a probiotic cocktail of four Lactobacillus species (JUP-Y4) modulated the microbiota community structure and promoted the abundance of potentially beneficial bacteria such as Akkermansia. Ampicillin administration led to a decline in Bacteroidetes from 46Á6 AE 3Á91% to 0Á264 AE 0Á0362%; the addition of JUP-Y4 restored this to 41Á4 AE 2Á87%. This probiotic supplementation was more effective than natural restoration, where the levels of Bacteroidetes were only restored to 29Á3 AE 2Á07%. Interestingly, JUP-Y4 treatment was more effective in the restoration of microbiota in faecal samples than in caecal samples. JUP-Y4 also significantly reduced the levels of D-lactate and endotoxin (lipopolysaccharide, LPS) in the serum of mice, and increased the expression of tight-junction proteins while reducing the production of inflammatory cytokines (TNF-a, IL-6, MCP-1, IFN-c and IL-1b) in the ileum and the colon of antibiotic-treated mice. Conclusions: JUP-Y4 not only promoted recovery from antibiotic-induced gut dysbiosis, but also enhanced the function of the gut barrier, reduced inflammation and lowered levels of circulating endotoxin in mice. Significance and Impact of the Study: Consumption of a mixture of Lactobacillus species may encourage faster recovery from antibiotic-induced gut dysbiosis and gut microbiota-related immune disturbance.
inflammatory diseases (Cho et al. 2012; Canova et al. 2014; Goulet 2015) . Furthermore, recent animal studies have confirmed that antibiotic exposure can induce gut microbiome alterations that ultimately affect host metabolic and inflammatory responses associated with inflammatory bowel disease (IBD), irritable bowel syndrome, necrotizing enterocolitis and chronic diarrhoea (Fouhy et al. 2012; Cox et al. 2014; Nobel et al. 2015) , as well as extra-intestinal disorders such as type 2 diabetes, food allergy, asthma and obesity (Swidsinski et al. 2008b; Tannock 2008; De et al. 2010) .
Several animal studies and human clinical trials have demonstrated the protective effects of dietary supplements comprised of particular strains of probiotic Lactobacillus, against gut diseases including antibioticassociated diarrhoea and Clostridium difficile infection (Mileti et al. 2009; Gao et al. 2010; Gareau et al. 2010; Kale-Pradhan et al. 2010; Zhu et al. 2011) . For example, Lactobacillus casei strain ATCC 334, inhibited the progression of colon cancer by mediating apoptosis through the c-Jun N-terminal kinase pathway (Konishi et al. 2016) . Consumption of Lactobacillus plantarum was reported to alleviate the side effects of antibiotic therapy, including the risk of nausea and developing loose or watery stools (Lonnermark et al. 2010) . Furthermore, administration of Lactobacillus rhamnosus and Lactobacillus helveticus prevented microbial dysbiosis in an IBD mouse model (Emge et al. 2016) . However, to date there have been few studies on the protective effects achieved using a combination of different lactic acid bacteria against antibiotic-induced alterations in intestinal microbiota and inflammation; this is despite the benefits of using mixtures of probiotics against other conditions, have been well-documented (Jernberg et al. 2007; Buffie et al. 2012; Brown et al. 2017) .
It is increasingly evident that many fermented foods contain live bacteria some of which are genetically similar to strains used as probiotics (Marco et al. 2017) , and there is evidence that Lactobacillus strains isolated from fermented foods can provide health benefits (Rousseaux et al. 2007) . The aim of this study was to evaluate the effectiveness of a mixture of four Lactobacillus species on restoration of gut microbiota and regulation of immunity in mice following treatment with antibiotic.
Material and methods

Culturing of bacteria
The strains of Lactobacillus species used in this experiment were isolated from Chinese traditional fermented foods and included: L. plantarum CCFM2602 and L. casei CCFM2710 isolated from a yogurt-like dairy product from Inner Mongolia; L. rhamnosus CCFM492 obtained from pickled Chinese cabbage; and L. helveticus CCFM671 isolated from fermented camels' milk from Xinjiang. All strains were held in long-term storage (at À80°C in 30% sterile glycerol) in the Culture Collection of the Food Microbiology (CCFM) of Jiangnan University. Prior to use the four strains described above were cultured in de Man Rogosa and Sharpe broth at 37°C overnight without shaking. The bacterial cultures were centrifuged and the pellets re-suspended in 0Á9% saline solution and mixed in equal volumes (the concentration of each strain was adjusted to 0Á5 9 10 9 CFU per 0Á2 ml using the plate counting method), to give a final concentration of 2 9 10 9 CFU per 0Á2 ml. The mixture of the four Lactobacillus strains was designated as Jiangnan University Probiotic-Ying 4 strains (JUP-Y4).
Animal experiments
The experimental protocol was approved by the Ethics Committee of Jiangnan University, Wuxi, China (JN no. 201501671), and every effort was made to minimize animal suffering. Four-week-old male C57BL/6J mice were purchased from Shanghai Slack Experimental Animal Co., Ltd. (China) and maintained in a designated pathogenfree facility.
After a 1-week acclimatization period, the mice were randomly allocated into two groups (Table 1) : the Control group (Cont; n = 6) which were fed a regular diet (ad libitum) throughout the experimental period and a second group of mice (n = 18) that all received ampicillin (500 mg kg À1 ) via oral gavage twice-daily for 14 days. After this modelling period, the mice in the second group were randomly allocated into three subgroups (n = 6 per group) as follows: the Ampicillin group (Amp) which was sacrificed (at 14 days); the Natural Restoration (NatR) group which received 0Á9% saline solution (0Á2 ml) via oral gavage for 4 weeks in addition to regular diet; and the Probiotics group (JUP-Y4) which received 2 9 10 9 CFU (0Á2 ml per dose) of JUP-Y4 preparation (in saline) via oral gavage for 4 weeks in addition to regular diet.
Throughout the experiment, the weight of each mouse was recorded twice weekly, and faecal samples were collected after 7, 14 and 28 days. Blood (0Á5-1Á5 ml) from each mouse was collected into anticoagulant tubes after sacrifice. At the end of the experiment, the remaining mice were sacrificed (both NatR and JUP-Y4 groups, at 14 days + 4 weeks) and tissues, including the colon, caecum (and its contents) and ileum, were excised and frozen immediately in liquid nitrogen before further analysis. To collect the faeces, the mice were placed in a sterile room and wiped lightly using 75% alcohol. Then fresh faecal samples were collected and transferred into sterile precooled tubes, and then stored at À80°C.
DNA extraction and 16S rRNA gene sequencing
Total genomic DNA was extracted from the faecal samples and also the contents of the caecum using the FastDNA Spin Kit for Soil (MP Biomedical, Solon, OH, USA) according to the manufacturer's instructions. The V4 region of the bacterial 16S rRNA gene was amplified from each sample with a forward (5 0 -AYT GGG YDT AAA GNG-3 0 ) and reverse (5 0 -TAC NVG GGT ATC TAA TCC-3 0 ) primer set and using the conditions described by Zhao et al. (2013) . After purification, the PCR products were quantified using a Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies, Carlsbad, CA, USA). Libraries were prepared using the TruSeq DNA LT Sample Preparation Kit (Illumina) and analysed on a MiSeq sequencer platform with the MiSeq Reagent Kit (500 cycles-PE; Illumina).
Bioinformatics analysis
Following removal of sequencing primers and barcode trimming, the sets of sequences that shared identity (>97%) were defined as operational taxonomic units (OTUs). These OTUs were assigned using the Ribosomal Database Project (RDP) Naive Bayes classifier (Wang et al. 2007) . Representative sequences from each cluster identified were aligned using the PyNAST aligner to the green genes core set in QIIME (Caporaso et al. 2010) , which was also used to calculate alpha and beta diversity and rarefaction curves. The Shannon diversity index was estimated to evaluate the ecological diversity of the microbiota in each sample. Similarity between the microbial communities was determined using a UniFrac analysis (Lozupone and Knight 2005) .
Enzyme-linked immunosorbent assays of blood and tissues
Blood samples were each centrifuged at 3000 g for 10 min. The sera were each mixed with limulus lysate reagent to evaluate endotoxin (lipopolysaccharide, LPS) levels (Cani et al. 2009) , and an enzymatic assay kit was used to determine D-lactate concentrations (Chen et al. 2012) . Ceca, ilea and colon tissue samples were each homogenized with a Scientz-50 tissue mill (Lanzhi, Ningbo, China). The resulting homogenates were centrifuged twice at 13,000 g for 10 min and the supernatants were transferred to fresh tubes. The levels of tumour necrosis factor alpha (TNF-a), monocyte chemotactic protein 1 (MCP-1), interleukin-6 (IL-6) and interferon-c (IFN-c) were determined using specific ELISA kits following the manufacturer's instructions (Nanjing SenBeiJia Biological Technology Co. Ltd., Nanjing, China).
Real-time RT-PCR
RNA was extracted from colon and ileal tissue samples using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) and reverse transcribed into cDNA using a Reverse Transcriptase kit following the manufacturer's instructions (Takara Shuzo, Kyoto, Japan). Gene expression was determined on a real-time quantitative PCR system (CFX Connect; Bio-Rad, Hercules, CA, USA), using appropriate primers and iTaq Universal SYBR green Supermix (Bio-Rad). Primer sets utilized for the determination of the gene expression of TNF-a were (forward 5-TAG CCA GGA GGG AGA ACA GA-3 and reverse 5-TTT TCT GGA GGG AGA TGT GG-3), IL-1b (forward 5-TTG AAG AAG AGC CCA TCC TC-3 and reverse 5-CAG CTC ATA TGG GTC CGA C-3), MCP-1 (forward 5-TCA CTG AAG CCA GCT CTC TCT-3 and reverse 5-GTG GGG CGT TAA CTG CAT-3), IFN-c (forward 5-CGG TGA GAA GAT GTT CCA TGC CAC-3 and reverse 5-TCT CCT TCA GGA CAA TGT CAA ACA-3). Relative quantification of the target gene was analysed using normalization with the b-actin gene (forward 5-GGCTGTATTCCCCTCCATCG-3 and reverse 5-CCAGTTGGTAACAATGCCATGT-3) and calculated according to the 2 ÀDDCT method (Livak and Schmittgen 2001) .
Statistical analysis
A one-way analysis of variance (ANOVA) and a Tukey's post hoc test were performed, and 95% A cocktail of Lactobacillus species was administered to mice via gavage in 0Á9% saline solution. Equal volumes of 0Á9% saline solution (0Á2 ml) were administered to the nontreatment group (Cont).
confidence intervals were used. The analyses were performed using SPSS software (SPSS Inc, Chicago, IL, USA). Comparisons between different groups were achieved using the two-tailed Student's t test (*P < 0Á05 and **P < 0Á01; GraphPad Prism ver. 5.00).
Differences were considered significant at a P < 0Á05. Data are presented as means AE SD.
Results
Impact of a mixture of Lactobacillus strains on antibiotic-induced intestinal physiology
Compared with the Cont group, antibiotic treatment (Amp group) significantly increased the caecal weight, as indicated by the caecum index (caecum weight/mouse weight) (P < 0Á01, Fig. 1 ). Caecal tumidity was still severe in NatR group where the caecum index was also significantly higher than the Cont group (P < 0Á01). However, in the JUP-Y4 treatment group, the caecum index was reduced to the same level as that in the control group. Gut permeability was indicated by the levels of endotoxin and D-lactate in the serum, which increased in the antibiotic group but decreased at a faster rate following JUP-Y4 treatment compared with the NatR group (Fig. 2 ). The expression of intestinal epithelial tight-junction proteins, including ZO-1, occludin and claudin-1, in the ileum and caecum segments was inhibited after antibiotic exposure but restored by the use of JUP-Y4 (Fig. 3) .
JUP-Y4 restores diversity of the gut microbiota in mice with antibiotic-induced dysbiosis
The calculated Shannon diversity index value ( ) for 2 weeks, Natural restoration (NatR) indicates oral gavage with 0Á9% saline solution for 4 weeks after ampicillin gavage and JUP-Y4 indicates oral gavage with a Lactobacillus cocktail (Lactobacillus plantarum CCFM2602, Lactobacillus casei CCFM2710, Lactobacillus rhamnosus CCFM492 and Lactobacillus helveticus CCFM671) for 4 weeks after gavage with ampicillin. Data are shown as means AE SDs. Two-tailed Student's t test determined statistical significance, **P < 0Á01 and ns, no significant difference. n = 6 mice per group. diversity index values in the NatR group (4Á52 AE 0Á20) were lower than both that of the Cont group (5Á98 AE 0Á38) and the JUP-Y4 group, the latter of which had the highest diversity value of 6Á56 AE 0Á26. The abundance matrix obtained from faecal samples was subjected to an unweighted UniFrac PCoA, which clearly separated the Amp group from the Cont group. The JUP-Y4 and NatR groups were distributed in between the other two groups (Fig. 4b) . Clustering of the group means, which was based on the Mahalanobis distances derived from PCoA scores, confirmed a statistically significant separation between the microbiota from the Cont, Amp, NatR and JUP-Y4 groups with the position of the JUP-Y4 group being much closer to the Cont group than the NatR group (Fig. 4c) . In summary, treatment with the probiotic, JUP-Y4, shifted the overall structure of the antibiotic-disrupted gut microbiota towards that of the Cont group.
Changes in the key phylotypes of gut microbiota are reversed by JUP-Y4 treatment after antibiotic exposure Gut microbiota analysis at the phylum level After antibiotic exposure, the gut microbiota in both the faeces and caecum were largely dominated by Proteobacteria (Fig. 5) . In faeces, the abundances of Firmicutes and Bacteroidetes were restored following treatment with JUP-Y4 to values more similar to those in the Cont group than in the NatR group (Fig. 5a) . In caecal samples, the phylum-level structure of the gut microbiota was even more disordered in the NatR group, where Firmicutes accounted for 61Á5 AE 2Á6% compared with 26Á8 AE 5Á7% in the Cont group (Fig. 5b) . The treatment with JUP-Y4 helped to decrease the relative levels of Firmicutes to 42Á2 AE 5Á3% which was still higher than the Cont group, reflecting the contribution of the added Lactobacillus species to the overall abundance of Firmicutes. Gut microbiota analysis at the genus level At the genus level, antibiotic treatment significantly increased the abundances of Staphylococcus, Acinetobacter, Azorhizophilus, Enterococcus and Pseudomonas relative to the Cont group in faeces, whereas the abundances of other genera decreased (Fig. 6) . In faecal samples, the JUP-Y4 treatment enriched the populations of Akkermansia, Alistipes and Porphyromonadaceae while reduced the abundances of Desulfovibrionales, Anaerotruncus, Sporobacter, Robinsoniella, Oscillibacter, Dorea, Ruminococcus, Clostridia and Helicobacter compared with the NatR group. Accordingly, the levels of these genera in the JUP-Y4 group were closer to the levels in the Cont group than levels in the NatR group. A cluster analysis in a heat map (Fig. 6 ) indicated that treatment with JUP-Y4 restored the gut microbiota structure and abundance to levels similar to those in the Cont group, whereas the NatR group struggled to reach the same levels following antibiotic treatment.
Results from caecal samples were consistent with results from faecal samples; the abundances of Acinetobacter, Burkholderia, Pseudomonas, Betaproteobacteria, Proteobacteria and Enterococcaceae increased in response to antibiotic use, whereas other genera decreased (Fig. 7) . However, in the case of the caecal samples, restoration of the microbiota following JUP-Y4 treatment was not different to that in the NatR mice cohort.
Consumption of a mixture of Lactobacillus species (JUP-Y4) improves immune function in the intestines of antibiotic-exposed mice
Antibiotic administration influenced intestinal immune cell homeostasis, the protein levels of TNF-a, IL-6, MCP- 1 and IFN-c were significantly higher in the colon and ileal tissues of antibiotic-exposed mice compared with the Cont treatment (Fig. 8) . Notably, levels of these inflammatory cytokines were reduced by varying degrees in the JUP-Y4 treatment compared with the NatR group. The expression of specific cytokines at the mRNA level was also determined. The transcript levels of TNF-a, IL1b, MCP-1 and IFN-c increased significantly in the colon and ilea of antibiotic-treated mice compared with the Cont group (Fig. S1 ). However, expression of these transcripts was reduced more following treatment with JUP-Y4, than in the NatR group.
Discussion
In this study, we used a mouse model of antibiotic exposure that exhibited significant alterations in intestinal bacterial communities and immune cell homeostasis. We observed that treatment with a cocktail of Lactobacillus species (JUP-Y4; containing L. plantarum, L. casei, L. rhamnosus and L. helveticus) derived from fermented foods restored the gut microbiota community structure, enhanced microbial diversity and reduced the intestinal inflammation caused by antibiotic administration.
It is noteworthy that there was a difference in the gut microbiota from faecal and caecal samples in the present study, as indicated by the more effective restoration of gut microbiota by JUP-Y4 in the former than the latter. Previous studies have also shown differences between the composition of caecal and faecal microbial communities in mice (Pang et al. 2012; Gu et al. 2013) . A report by Tanca et al. (2017) indicated that taxon-specific functions, oxalate degradation and glutamate metabolism varied between microbiota communities from caecal and faecal samples. The beneficial modulatory effects of treatment with a cocktail of Lactobacillus species following antibiotic exposure were greater in microbiota from faecal samples than microbiota from caecal samples, implying that the probiotic cocktail was more effective in the colon than in the caecum.
A single dose of antibiotic is sufficient to induce gut microbiota dysbiosis (Knoop et al. 2016) . In susceptible hosts, these antibiotic treatments could trigger intestinal dysbiosis and systemic bacterial translocation (Sartor 2008; Shaw et al. 2010 Shaw et al. , 2011 . A previous study also showed that commensal bacteria affected the expression of host genes associated with mucosal barrier function, xenobiotic metabolism and nutrient absorption (Hooper et al. 2001) . These antibiotic-induced subclinical intestinal abnormalities favour the expansion of opportunistic microbes, enhance inflammatory responses and ultimately lead to the development of chronic diseases, although in this study we did not study the antibiotic treatment in the context of any specific disease. Serum D-lactate and endotoxin levels were measured as markers of gut permeability (Bischoff et al. 2014) . Several pathologies including gastrointestinal diseases and metabolic syndrome have been linked to alteration of intestinal barrier function
(a) (b) Figure 5 Relative abundances of the main phyla after antibiotic exposure and restoration following administration of a mixture of Lactobacillus species (JUP-Y4). The abundances of microbial phyla in faecal samples (a) and caecum content samples from different groups (b). Data are expressed as means AE SDs. n = 6 mice per group. All of group names correspond to those described in the legend of Figure 1 , the different colours of legends represent different phyla, ( ) Actinobacteria, and permeability of the gut epithelium (Sun et al. 2001; Camilleri et al. 2012) . In our study, we have demonstrated that the antibiotic administration to mice increased the levels of serum D-lactate and endotoxin. The mechanisms accounting for the protective effect of JUP-Y4 against intestinal dysbiosis may be attributed to three aspects: modulation of the gut microbiota community structure; promotion of beneficial bacteria; and activation of the host-adaptive immune system. The composition of the intestinal microbiome fluctuated for 2 weeks in response to the administration of oral antibiotics. At both phylum and genus level, the structure and abundance of gut microbiota could be restored by the use of our cocktail JUP-Y4. The JUP-Y4 probiotic treatment promoted beneficial bacteria, and these oligosaccharides and short-chain fatty acids producing bacteria can stimulate microbial interactions, the hosts immune responses, and metabolic signalling .
In the present study, antibiotic-induced changes in the gut microbiota were better restored by treatment with the JUP-Y4 cocktail than via natural recovery. We observed that it was difficult to reduce the abundance of some opportunistic pathogenic bacteria, including Desulfovibrionales, Clostridia and Helicobacter during natural recovery. However, probiotic treatment decreased the abundance of Desulfovibrionales, which are associated with Crohn's disease (Chiodini et al. 2015) and human infections such as appendicitis and cholecystitis (Swidsinski et al. 2008a; Kaakoush et al. 2012) . In addition, the abundances of some beneficial bacteria, such as Akkermansia species, increased in higher levels following probiotic treatment than during natural recovery. Akkermansia species are thought to be biomarkers for intestinal health (Swidsinski et al. 2011) and their abundance is inversely correlated with the severity of Crohn's disease, ulcerative colitis (Png et al. 2010) , appendicitis, obesity (Santacruz et al. 2010 ) and paediatric autism (Wang et al. 2011) . Moreover, the micro-organisms isolated from fermented food could alter the composition and function of the intestinal microbiota, although the significance of these changes and their importance to probiotic efficacy is under debate (van Hylckama Vlieg et al. 2011; KatoKataoka et al. 2016) . In this study, we have showed the JUP-Y4 is able to modulate the microbiota more effectively after antibiotic-induced disturbance. Antibiotic-exposed mice are known to produce higher levels of pro-inflammatory cytokines, including TNF-a, IL-6, MCP-1 and IFN-c in intestinal tissues than the untreated mice (Suzaki et al. 1999; Knoop et al. 2016) . In this study, we also detected increases in the levels of these four cytokines following ampicillin treatment. The application of JUP-Y4 decreased intestinal inflammation in antibiotic-treated mice with associated reductions in levels of all four cytokines when quantified either at the protein level or by transcription analysis. In another study a strain of L. paracasei was also able to downregulate the expression of the IL-6 and TNF-a in neomycinadministered mice which suffered from Crohn's disease (Verd u 2006) . Furthermore, some probiotics have been shown to activate anti-inflammatory mechanisms and regulate mucosal immune responses (Gareau et al. 2010) . For example, L. casei DN-114001 attenuated pathogenic activation of the pro-inflammatory signal transduction cascade by inhibiting the NF-jB signal transduction pathway (Tien et al. 2006) . In other hand, the tight junction integrity could strengthen the intestinal barrier, thus limiting the ability of antigens to enter the body and prevent adverse immune responses. Lactobacillus plantarum MB452 up-regulated the expression of four tight junction proteins (occludin, ZO-1, ZO-2 and cingulin) and some proteasome-associated genes in Caco-2 cells, which indicated protection of intestinal barrier function by this probiotic (Anderson et al. 2010) . Lactobacillus plantarum CCFM8610 (Zhai et al. 2016 ) reversed disruption of tight junctions, alleviated inflammation and decreased intestinal permeability in mice with chronic cadmium exposure. Similarly, L. rhamnosus GG ameliorated chronic alcoholic liver disease by positively modulating intestinal tight junctions via miR122a regulation (Zhao et al. 2015) . In such antibiotic-induced mice, mucosal inflammation and various aspects of immune function have been influenced either directly or indirectly by the gut microbial signal. The mixture of Lactobacillus species in JUP-Y4 reported in this study improved tight junction integrity of the intestinal epithelial cells. In summary, antibiotic-induced changes in the development or composition of the gut microbiota and intestinal barrier integrity can disturb the relationship between the microbiota and the host immune system, eventually leading to altered immune responses, which may underlie multiple host inflammatory disorders. The ability of JUP-Y4 to modulate antibiotic-induced gut dysbiosis is reflected in the restoration of the gut microbiota and intestinal barrier, suggesting the potential for this probiotic mixture to restore gut homeostasis much faster than by natural restoration after the cessation of antibiotic treatment. Although the translation of these outcomes to clinical practice needs further clinical research, probiotic interventions intended to selectively promote bacteria could become an important dietary strategy to enhance recovery from dysbiosis and related immune disturbances associated with antibiotic use.
